Competitor News, Europe, Government/Regulatory, International, RWE Study

The impact of the use of Real-World Evidence (RWE) for NICE submissions

Real World Evidence (RWE) refers to scientific evidence generated from observational data collected during routine clinical care. Following the NICE methods review, the latest NICE Health Technology Evaluation Manual formalises the acceptability of RWE as a source of evidence. While in general Randomised Clinical Trials (RCTs) remain the gold standard for clinical…

Collaborations, Competitor News

Clarify Health Expands Strategic Partnership with Datavant to Connect Real-World Data and First-Party Data Across Life Sciences

Datavant’s privacy-preserving tokenization and high-accuracy matching technologies will be used to link real-world data with first-party datasets like clinical trial data and specialty pharmacy data Clarify Health’s Atlas analytics platform has mapped payer-complete, real-world patient journeys that will be linked to first-party datasets across life sciences to deliver novel patient…

Industry News, Synthetic Data

Generation of realistic synthetic data using Multimodal Neural Ordinary Differential Equations

Abstract Individual organizations, such as hospitals, pharmaceutical companies, and health insurance providers, are currently limited in their ability to collect data that are fully representative of a disease population. This can, in turn, negatively impact the generalization ability of statistical models and scientific insights. However, sharing data across different organizations…

Blogs/Publications, Competitor News, RWE Study

Accelerate and de-risk drug development programs with multimodal data

Introduction For decades, the biopharmaceutical industry has used single sources of real-world data, including claims, electronic health records (EHRs), and cancer registries. Yet no one had amassed a large, harmonized dataset from hundreds of hospitals that included abstracted clinical notes, longitudinal EHR information, tumor and germline DNA sequencing data, whole…

Clinical Trials, Collaborations, Competitor News, Oncology

Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials

Oncology patients and clinical research sponsors benefit from Syapse’s real-world data intelligence and Science 37’s agile trial operating system to help accelerate the identification and participation of eligible participants August 18, 2022 07:55 ET | Source: Science 37, Inc. RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, Aug. 18, 2022 (GLOBE NEWSWIRE) —…

Competitor News, HR

Interoperability Champion Steven Lane, MD, MPH, Joins Health Gorilla as Chief Medical Officer

Mountain View, California, Aug. 16, 2022 (GLOBE NEWSWIRE) — Health Gorilla, a leading Health Information Network and interoperability provider, announced today it has appointed Steven Lane, MD, MPH, former Clinical Informatics Director at Sutter Health, as Chief Medical Officer (CMO). In his new role, Dr. Lane will lead Health Gorilla’s…

Collaborations, Competitor News

Arcadia Research Data Now Available on Prognos Marketplace

First source of electronic health record data available on platform provides life science organizations with deeper clinical insights for therapy optimization  BOSTON, Aug. 15, 2022 /PRNewswire/ — Arcadia, the leading data analytics platform for healthcare and life sciences, today announced its availability through Prognos Marketplace. Prognos is solving for disconnected, siloed data that cannot…

China, Collaborations, Competitor News, Data Partnership, Oncology, RWE Study

BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care

Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines August 15, 2022 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines…

Academic, HR, Partner and Collaborator News

Dr. Maia Hightower named UChicago Medicine Chief Digital & Technology Officer

Maia Hightower, MD, MBA, MPH, an internist and accomplished healthcare IT executive, has been named the University of Chicago Medicine’s new Executive Vice President and Chief Digital & Technology Officer effective August 15, 2022. Hightower is CEO and co-founder of Equality AI, a startup that helps clinical teams achieve health equity…